Targeted Cancer Agents Flashcards
Tamoxifen
Toremifene
SERM (antiestrogen)
Toxicity: fatigue, hot flashes, mood swings, vaginal discharge, fluid retention, nausea, thromboembolic events, endometrial hyperplasia
Fulvestrant
SERD (antiestrogen)
Toxicity: fatigue, hot flashes, mood swings, vaginal discharge, fluid retention, nausea, thromboembolic events, endometrial hyperplasia
Exemestane
Letrozole
Anastrozole
Aromatase Inhibitor
Block production of estrogen
Toxicity: fatigue, hot flashes, nausea, hypercholesterolemia, arthralgias, bone fractures, weight gain
Bicalutamide
Enzalutamide
Antiandrogen
Block 5 alpha reductase
Toxicity: hot flashes, N/V, LFT abnormalities, gynecomastia, gal actor Rhea, interstitial pneumonitis, edema, HTN, HA
Abiraterone
Antiandrgen
Block testosterone production by binding CYP17
Toxicity: edema, joint swelling, hypokalemia, hot flashes, HTN, increased urinary frequency, URI, LFT abnormalities, lab abnormalities
Lauprolide
Goserelin
Triptorelin
LHRH agonist
Activates pathway because negative feedback loop which eventually causes the pathway to shut down
Toxicity: hot flashes, decreased libido, impotence, gynecomastia, tumor flare
Abarelix
GnRH antagonist
Directly block production of LH and FSH
Toxicity: life threatening allergic reactions, hot flashes, breast enlargement/pain, tiredness
Degarelix
GnRH antagonist
Directly block production of LH and FSH
Toxicity: Injection site reactions, hot flashes, weight increase, increases in transaminases
Bevacizumab
VEGF inhibitor (antibody)
Binds to circulating VEGF, prevents ligand from binding to receptor
Toxicity: Infusion related reaction, bleeding, thromboembolism, proteinuria, HTN, GI perforation, Reversible posterior leukoencephalopathy syndrome (RPLS), nephrotoxic
Ziv-aflibercept
VEGF inhibitor (antibody)
VEGF-trap, recombinant fusion protein
Toxicity: infusion related reaction, bleeding, thromboembolism, proteinuria, HTN, GI perforation, RPLS, myelosuppression, elevated LFTs, dysphonia, diarrhea
Ramucirumab
VEGF inhibitor (antibody) VEGFR2 antagonist (binds to receptor) Toxicity: infusion related reaction, bleeding, thromboembolism, proteinuria, HTN, GI perforation, RPLS
Sunitinib
VEGF inhibitor (small molecule) Multiple Tyrosine Kinase inhibitor Toxicity: Diarrhea, rash, hand-foot reaction, HTN, bleeding, skin/hair discoloration, CHF, QT prolongation, hypothyroidism, hepatotoxicity
Regorafenib
VEGF inhibitor (small molecule)
MTKI
Toxicity: Fatigue/asthenia, decreased appetite, hand-foot syndrome, diarrhea, mucositis, HTN, dysphonia, hepatotoxicity, hemorrhage
Sorafenib
VEGF inhibitor (small molecule) MTKI Toxicity: rash, hand-foot syndrome, diarrhea, HTN, QT prolongation, drug induced hepatitis, hypophosphatemia
Cetuximab
Panitumumab
EGFR inhibitor (antibody)
EGFR 1 antibody
Toxicity: infusion related reaction, acneform rash, malaise, diarrhea, electrolyte wasting (Mg), pulmonary toxicity